Moleculin Biotech, Inc. (MBRX) Stock Price History
Historical prices from 2016 to 2026
Loading 10-year price history...
MBRX Historical Performance
Short-Term Returns
MBRX Stock Price Trajectory (2016–2026)
As of May 8, 2026, Moleculin Biotech, Inc. (MBRX) trades at $2.49, representing a +149.2% return over the past year. The stock has delivered a -95.0% total return over five years (-45.2% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $862.20 on June 6, 2016. From this peak, MBRX has corrected -99.7%, currently trading 67% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers SNDX (+105.6% 1Y), IMVT (+96.1% 1Y), and AGIO (-2.4% 1Y), MBRX has underperformed the peer group average. Compare MBRX vs SNDX →
MBRX Historical Price Data (2025–2026)
Showing 30 of 2,498 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 2.50 | 2.56 | 2.45 | 2.49 | 70K | +0.40% |
| 2026-05-06 | 2.49 | 2.55 | 2.48 | 2.48 | 52K | -0.40% |
| 2026-05-05 | 2.50 | 2.53 | 2.48 | 2.49 | 47K | +0.40% |
| 2026-05-04 | 2.52 | 2.59 | 2.42 | 2.48 | 118K | -1.20% |
| 2026-05-01 | 2.52 | 2.58 | 2.49 | 2.51 | 25K | -1.95% |
| 2026-04-30 | 2.48 | 2.58 | 2.46 | 2.56 | 68K | +1.99% |
| 2026-04-29 | 2.52 | 2.54 | 2.46 | 2.51 | 75K | -1.95% |
| 2026-04-28 | 2.56 | 2.61 | 2.52 | 2.56 | 131K | +0.79% |
| 2026-04-27 | 2.52 | 2.56 | 2.46 | 2.54 | 100K | 0.00% |
| 2026-04-24 | 2.54 | 2.62 | 2.50 | 2.54 | 99K | 0.00% |
| 2026-04-23 | 2.47 | 2.58 | 2.29 | 2.54 | 544K | +1.60% |
| 2026-04-22 | 2.54 | 2.54 | 2.42 | 2.50 | 58K | -1.19% |
| 2026-04-21 | 2.57 | 2.60 | 2.48 | 2.53 | 59K | -1.17% |
| 2026-04-20 | 2.39 | 2.58 | 2.35 | 2.56 | 109K | +5.79% |
| 2026-04-17 | 2.44 | 2.48 | 2.38 | 2.42 | 95K | +0.83% |
| 2026-04-16 | 2.39 | 2.44 | 2.36 | 2.40 | 108K | -1.64% |
| 2026-04-15 | 2.46 | 2.46 | 2.37 | 2.44 | 132K | -2.01% |
| 2026-04-14 | 2.73 | 2.73 | 2.44 | 2.49 | 155K | -8.46% |
| 2026-04-13 | 2.62 | 2.77 | 2.60 | 2.72 | 64K | +3.82% |
| 2026-04-10 | 2.54 | 2.65 | 2.52 | 2.62 | 54K | +2.75% |
| 2026-04-09 | 2.44 | 2.58 | 2.42 | 2.55 | 109K | +4.94% |
| 2026-04-08 | 2.60 | 2.61 | 2.41 | 2.43 | 82K | +0.83% |
| 2026-04-07 | 2.33 | 2.44 | 2.33 | 2.41 | 66K | +3.88% |
| 2026-04-06 | 2.31 | 2.35 | 2.30 | 2.32 | 41K | 0.00% |
| 2026-04-02 | 2.22 | 2.32 | 2.22 | 2.32 | 60K | +4.04% |
| 2026-04-01 | 2.26 | 2.30 | 2.20 | 2.23 | 58K | -2.62% |
| 2026-03-31 | 2.22 | 2.32 | 2.21 | 2.29 | 75K | +2.23% |
| 2026-03-30 | 2.35 | 2.40 | 2.21 | 2.24 | 107K | -8.20% |
| 2026-03-27 | 2.40 | 2.44 | 2.34 | 2.44 | 60K | +0.41% |
| 2026-03-26 | 2.47 | 2.52 | 2.40 | 2.43 | 109K | -2.41% |
See MBRX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MBRX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MBRX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMBRX — Frequently Asked Questions
Quick answers to the most common questions about buying MBRX stock.
How has MBRX stock performed recently?
MBRX returned +149.2% over the past year, beating its 5-year annualized CAGR of -45.2%. The stock trades below its 200-day moving average, confirming the uptrend.
What is MBRX's all-time high price?
Moleculin Biotech, Inc. reached $862.20 on 2016-06-06. The 52-week high is $7.98. Current 1-year return of +149.2% places the stock closer to historical peaks.
Where can I download MBRX historical price data?
This page provides MBRX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.